Atlas FDA

GELFOAM

FDA premarket approval N18286/S028 · decided 2018-03-01

Approval details

PMA number
N18286
Supplement
S028
Supplement type
Normal 180 Day Track
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
GELFOAM
Generic name
Agent, absorbable hemostatic, collagen based
Applicant
Pfizer, Inc.
Date received
2016-04-20
Decision date
2018-03-01
Days to decision
680 days
Decision code
APPR
Product code
LMF
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Ny, NY
Statement
Approval for an alternative packaging configuration for GELFOAM Sterile Powder under the trade name FLOSTAT NT as well as approval of the associated new manufacturing site for GELFOAM Sterile Powder manufacture (solely for FLOSTAT NT), kit assembly, secondary packaging, and sterilization at Vascular Solutions, Inc., 6464 Sycamore Court, Minneapolis, Minnesota.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ThermaCare Quick Therapy TENS (K181102)Pfizer, Inc.2018-09-15
VISINE FOR CONTACTS (K991620)Pfizer, Inc.1999-09-24
ORALCHEK SUPER-SOFT BRUSH (K892264)Pfizer, Inc.1989-06-14
WATER JEL STERILE GEL-SOAKED BURN DRESSING (K892360)Pfizer, Inc.1989-06-05
PFIZER HOSPITAL PRODUCTS GROUP ACL DRILL GUIDE (K881378)Pfizer, Inc.1988-06-17
MEDI-WIPES UNITED ANTISEPTIC SKIN PREP (K854726)Pfizer, Inc.1986-02-24
MEC HIP BOLT (K850413)Pfizer, Inc.1985-07-15
MEC ROD CONNECTOR (K850443)Pfizer, Inc.1985-07-15